Wang, J., He, Qy. Thinking on how to construct the system of Chinese medicine efficacy evaluation for coronary heart disease angina pectoris., Chin. J. Integr. Med. 16, 75–78 (2010). https://doi.org/10.1007/s11655-010-0075-2
Jie Wang, Qing-yong He. Thinking on how to construct the system of Chinese medicine efficacy evaluation for coronary heart disease angina pectoris[J]. Chinese Journal of Integrative Medicine, 2010,16(1):75-78.
Wang, J., He, Qy. Thinking on how to construct the system of Chinese medicine efficacy evaluation for coronary heart disease angina pectoris., Chin. J. Integr. Med. 16, 75–78 (2010). https://doi.org/10.1007/s11655-010-0075-2DOI:
Jie Wang, Qing-yong He. Thinking on how to construct the system of Chinese medicine efficacy evaluation for coronary heart disease angina pectoris[J]. Chinese Journal of Integrative Medicine, 2010,16(1):75-78. DOI: 10.1007/s11655-010-0075-2.
Thinking on how to construct the system of Chinese medicine efficacy evaluation for coronary heart disease angina pectoris
摘要
The existing efficacy evaluation for coronary heart disease (CHD) angina pectoris does not demonstrate the characteristics and advantages of Chinese medicine (CM)
so a new system of efficacy evaluation which can scientifically and systematically reflect the specific features of CM needs to be urgently set up. Based on wide references of efficacy evaluations of CHD angina pectoris from our country and abroad
and considering the general acceptance by academic circles and demonstration of the characteristics of CM
this paper tries to set up a new index system of efficacy evaluation
combining both disease and syndrome differentiation for CHD angina pectoris. This paper also offers some explorations based on the results of clinical trials. The system is composed of six aspects
including efficacy evaluation of “disease”
syndrome factors and main endpoints (the incidence of important clinical events)
as well as patient reported outcomes
safety evaluation and medical economics.
Abstract
The existing efficacy evaluation for coronary heart disease (CHD) angina pectoris does not demonstrate the characteristics and advantages of Chinese medicine (CM)
so a new system of efficacy evaluation which can scientifically and systematically reflect the specific features of CM needs to be urgently set up. Based on wide references of efficacy evaluations of CHD angina pectoris from our country and abroad
and considering the general acceptance by academic circles and demonstration of the characteristics of CM
this paper tries to set up a new index system of efficacy evaluation
combining both disease and syndrome differentiation for CHD angina pectoris. This paper also offers some explorations based on the results of clinical trials. The system is composed of six aspects
including efficacy evaluation of “disease”
syndrome factors and main endpoints (the incidence of important clinical events)
as well as patient reported outcomes
safety evaluation and medical economics.
关键词
coronary heart disease angina pectorisChinese Medicineevaluation system
Keywords
coronary heart disease angina pectorisChinese Medicineevaluation system
references
Ministry of Health, PR China. Guiding principle of clinical research on new drugs of traditional Chinese medicine. Beijing: China Medic-Pharmaceutical Sciences and Technology Publishing House; 2002:68–73.
State Administration of Traditional Chinese Medicine. Standard of syndrome diagnosis and curative effect of traditional Chinese medicine. Nanjing: Nanjing University Publishing House; 1994:204.
Shen SG, Yao JC. Chinese medicine diagnosis and efficacy evaluation for cornoary heart disease angina pectoris. Chin J Tradit Chin Med Pharm (Chin) 2004;19:581–583.
Zhao DH, Jiang BQ. European guidance on clinical investigation on medicinal products for the treatment of angina. Chin J Clin Pharm (Chin) 1999;15:151–153.
Wang J, Li J, Yang G, Yao KW. Technical lines and methods of establishing syndrome diagnostic measuringscale for CAD angina pectoris. World Sci Techno-Modern Tradit Chin Med (Chin) 2007;9:13–17.
Sun ZQ. Comprehensive evaluation methods of medical and application. Beijing: Chemical Industry Publishing House, 2006:49–50.
Dai RW, Cao LB. Research of hall for workshop of metasynthetic engineering. J Manage Sci Chin (Chin) 2002;5(3):11–17.
Fleming TR, De Mets DL. Surrogate endpoints in clinical trials: are we being misled? Ann Intern Med 1996;125:605–613.
Song J, Chen KJ. Pondering over some problems in evaluating clinical efficacy of Chinese medicine. Chin J Integr Tradit West Med (Chin) 2003;23:564–565.
The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995;41:1403–1409.
U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. 2006;4:79.
Wu XF, Lai SL, Liang WX. Choice and application of the outcome indexes for clinical effectiveness assessment of traditional Chinese medicine. J Guangzhou Univ Tradit Chin Med (Chin) 2002;19:251–255.
Jin L, Wang J, Wang T. Evaluation on effects of disassembled formulas of Xuefu Zhuyu Decoction for treatment of angina pectoris using Seattle Angina Questionnaire. Chin J Integr Med (Chin) 2007;27:18–20.
Na KX, Yu P. Reasonable application of nitrate esters. Intern J Emerg Crit Care Med (Chin) 2006;3:1379–1381.
Wang J, Jin L. A clinical study of separated complex prescriptions based on disease and syndrome. World Sci Technol-Modern Tradit Chin Med (Chin) 2007;9:16–20.
Wang J, He QY, Xin YW, Li HX, Wang SH, Fang YT. Health economics of clinical angina pectoris. World Sci Technol-Modern Tradit Chin Med (Chin) 2008;10:17–21.
Future view and development of immunology: Exploring the immunology based on Chinese medicine and culture
Cost-effectiveness analysis of combined Chinese medicine and Western medicine for ischemic stroke patients
Objective tongue inspection on 142 liver cancer patients with damp-heat syndrome
Effect of Ermiao Recipe (二妙方) with medicinal guide Angelicae Pubescentis Radix on promoting the homing of bone marrow stem cells to treat cartilage damage in osteoarthritis rats
Effects of Jianpi Jiedu Recipe (健脾解毒方) on reversion of P-glycoprotein-mediated multidrug resistance through COX-2 pathway in colorectal cancer
相关作者
暂无数据
相关机构
Georg-August-Universität Göttingen, Göttingen
The Key Laboratory of Geriatrics, Beijing Hospital and Beijing Institute of Geriatrics’ Ministry of Public Health
Medical Informatics Center, Peking University
Department of Hospital Management, Peking University Health Science Center, Peking University
Neurology Department of Peking University Third Hospital, Peking University